AA
AGN

Advisory Alpha’s Allergan plc AGN Stock Holding History

Advisory Alpha’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-125
Closed -$23.2K – 693
2020
Q1 		$23.2K Buy
125
+24
+24% +$4.52K 0.01% 293
2019
Q4 		$19.3K Buy
101
+78
+339% +$14.1K ﹤0.01% 410
2019
Q3 		$3.83K Buy
+23
New +$3.75K ﹤0.01% 576
2019
Q2 		– Sell
-15
Closed -$2.1K – 722
2019
Q1 		$2.1K Buy
+15
New +$2.17K ﹤0.01% 547

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Advisory Alpha's AGN Position: Q2 2020 in Review

Advisory Alpha sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 125 shares — an estimated $23.2K sold.

Advisory Alpha first reported a position in AGN in Q1 2019 and held it in 4 quarters. The position peaked at $23.2K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Advisory Alpha reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Advisory Alpha sold 125 Allergan plc shares in Q2 2020, an estimated $23.2K.
  • Advisory Alpha first reported a position in Allergan plc in Q1 2019 and held it in 4 quarters.
  • Advisory Alpha's Allergan plc position peaked at $23.2K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Advisory Alpha's 13F filing for Q2 2020, filed 14 Aug 2020.